Case Report
Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
Table 1
Pulmonary function tests from Case 1.
| | 8 May 2007 | 31 March 2014 | 11 July 2014 | 22 October 2014 | 1 November 2018 | 11 October 2019 | 15 October 2020 |
| FVC | | | | | | | | L | 3.26 | 2.73 | 3.04 | 2.95 | 2.41 | 2.04 | 1.78 | % predicted | 97 | 80 | 89 | 92 | 75 | 53 | n/a | FEV1 | | | | | | | | L | 2.30 | 2.02 | 2.11 | 1.88 | 1.83 | n/a | n/a | % predicted | 84 | 77 | 80 | 72 | 71 | n/a | n/a | FEV1/FVC | 71 | 74 | 69 | 64 | 76 | n/a | n/a | DLCO | | | | | | | | mL/mmHg/min | 13.3 | 14.14 | 14.60 | 13.5 | 13.62 | 11.2 | 10.3 | % predicted | 63 | 64 | 67 | 80 | 85 | 77 | n/a |
|
|
DLCO: diffusing capacity for carbon monoxide; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; n/a: not available.
|